iSpecimen Inc. (ISPC) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -543.7%, revenue growth -78.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.93M |
| Revenue (TTM) | $0.0B |
| Net Margin | -543.7% |
| Return on Equity | -657.7% |
| Operating Margin (TTM) | -2020.0% |
| Debt / Equity | 0.58 |
| Current Ratio | 0.82 |
| Net Debt / EBITDA | 0.4 |
| Interest Coverage | -1537.6 |
| Revenue Growth (YoY) | -78.7% |
| EPS Growth (YoY) | 133.3% |
| EV / EBITDA | -0.0 |
| Price / Book | 2.18 |
| Price / Sales | 8.10 |
| FCF Yield | -185.4% |
| Altman Z-Score | -6.10 (distress) |
| Industry P/E (Business Services) | 28.3 |
| Sector P/E (Technology) | 31.8 |
ISPC overview · ISPC earnings · ISPC KPIs · ISPC documents · ISPC ownership · ISPC peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.